1The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.Major outcomes in moderately hypercholesterolemic,hypertensive patients randomised to pravastatin vs usual care.JAMA,2002,288(23):2998-3007.
2Sever PS,Dahlof B,Poulter NR.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):a multicentre randomised controlled trial.Lancet,2003,361(9364):1149-1158.
3Scalia R,Gooszen ME,Jones SP.Simvastatin exerts both antiinflammatory and cardioprotective effects in apolipoprotein Edeficient mice.Circulation,2001,103(21):2598-2603.
4Shepherd J,Cobbe SM,Ford I,et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.West of Scotland Coronary Prevention Study Group.N Engl J Med,1995,333(12):1301-1307.
5Ridker PM,Danielson E,Fonseca FA.Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein.N Engl J Med,2008,359(21):2195-2207.
6Tan KC,Chow WS,Tam SC.et al.Atorvastatin lowers C-reactive protein and improve endothelium-dependent vasodilation in type 2 diabetes mellitus.JCEM,2002,87(2):563-568.
